Google快讯 - lung cancer

	lung cancer 实时更新 ⋅ 2025年1月3日
	新闻
	PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated ... Journal of Translational Medicine - BioMed Central Non-Small Cell Lung Cancer (NSCLC) is the leading cause of cancer death worldwide. Although immune checkpoint inhibitors (ICIs) have shown ... 标记为不相关
	Evidence for a reduction in number of cycles of immune checkpoint inhibitors - The Lancet The Lancet ... lung cancer, optimal duration of immune therapy will now be a requirement. We hope that other cancers will soon follow. In addition to the ... 标记为不相关
	Effect Of Interleukin-15 Stimulated NK-EVs And Carboplatin On Osimertinib-Resistant Lung ... Bioprocess Online This white paper explores a promising new approach to treating Osimertinib-resistant lung cancer, specifically focusing on H1975 cells with EGFR ... 标记为不相关
查看更多结果 | 修改此快讯

您收到此电子邮件是因为您订阅了Google快讯。 退订 | 查看您所有的快讯

以RSS Feed的形式接收此快讯

发送反馈